Diuretic Use and Subsequent Electrolyte Supplementation in a Level IV Neonatal Intensive Care Unit.

Area of Science:

• Neonatal Medicine
• Pediatric Pharmacology
• Clinical Chemistry

Background:

• Diuretics are commonly prescribed for fluid management in neonatal intensive care units (NICUs).
• Electrolyte disturbances are a known complication of diuretic therapy in infants.
• Understanding the specific risks associated with different diuretics and patient populations is crucial for optimizing care.

Purpose of the Study:

• To investigate the association between diuretic administration and serum electrolyte abnormalities in NICU infants.
• To determine the frequency of electrolyte supplementation requirements during diuretic therapy.
• To identify risk factors, such as gestational age and diuretic type, for adverse electrolyte events.

Main Methods:

• A retrospective cohort study was conducted in a Level IV NICU.
• Infants under 6 months receiving 2+ consecutive doses of specific diuretics (furosemide, thiazides, or combination) were included.
• The primary outcome measured was the incidence of electrolyte abnormalities or supplementation within 30 days of diuretic exposure.

Main Results:

• 92% of infants on diuretics experienced at least one electrolyte derangement or required supplementation.
• Infants born at later gestational ages (36-41 weeks) receiving thiazides had a significantly lower incidence (37%) of adverse events.
• Potassium and bicarbonate were the most commonly affected electrolytes, with furosemide showing a higher incidence of potassium derangement.

Conclusions:

• Diuretic therapy in neonates frequently results in electrolyte disturbances and necessitates supplementation.
• Infants born at earlier gestational ages appear to be at increased risk for these diuretic-induced electrolyte complications.
• Careful monitoring and consideration of gestational age are important when prescribing diuretics to infants.